Pfizer drops India vaccine application after regulator seeks local trial

Sharing is Caring!

When asked to participate in the trial or lose 1.4 billion customers, they chose to lose the customers.

Most maintstream media is silent on this.

Pfizer has withdrawn an application for emergency-use authorization of its Covid-19 vaccine in India that it has developed with Germany’s BioNTech, the company told Reuters on Friday.

The U.S. company, which was the first drugmaker to apply for emergency use authorization of its Covid-19 vaccine in India, had a meeting with the country’s drugs regulator on Wednesday and the decision was made after that, the company said.

See also  10 dead, 100 hospitalized after taking off-brand OZEMPIC

“Based on the deliberations at the meeting and our understanding of additional information that the regulator may need, the company has decided to withdraw its application at this time,” it said in a statement to Reuters.

“Pfizer will continue to engage with the authority and re-submit its approval request with additional information as it becomes available in the near future.”

www.cnbc.com/2021/02/05/pfizer-withdraws-application-for-emergency-use-of-its-covid-19-vaccine-in-india.html

See also  Nevada Supreme Court Rules Mail-In Ballots without Postmarks Can Be Counted Three Days After Election

www.thehindu.com/news/national/pfizer-withdraws-emergency-use-authorisation-application-for-its-covid-19-vaccine-in-india/article33757258.ece

h/t BFD


Views: 272

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.